Neutrophil Gelatinase-Associated Lipocalin as a Marker for Renal Dysfunction Detection in Critically Ill Patients with Increased Intraabdominal Pressure

Open access

Abstract

Introduction: Elevated intraabdominal pressure (IAP) it is known to have an impact on renal function trough the pressure transmitted from the abdominal cavity to the vasculature responsible for the renal blood flow. Intraabdominal pressure is found to be frequent in intensive care patients and also to be a predictor of mortality. Intra-abdominal high pressure is an entity that can have serious impact on intensive care admitted patients, studies concluding that if this condition progresses to abdominal compartment syndrome mortality is as high as 80%.

Aim: The aim of this study was to observe if a link between increased intraabdominal pressure and modification in renal function exists (NGAL, creatinine clearance).

Material and Method: The study enrolled 30 critically ill patients admitted in the Intensive Care Unit of SCJU Tîrgu Mures between November 2015 and August 2016. The study enrolled adult, hemodynamically stable patients admitted in intensive critical care - defined by a normal blood pressure maintained without any vasopressor or inotropic support, invasive monitoring using PICCO device and abdominal pressure monitoring.

Results: The patients were divided into two groups based on the intraabdominal pressure values: normal intraabdominal pressure group= 52 values and increased intraabdominal group= 35 values. We compared the groups in the light of NGAL values, 24 hours diuresis, GFR and creatinine clearance. The groups are significantly different when compared in the light of NGAL values and GFR values. We obtained a statistically significant correlation between NGAL value and 24 hour diuresis. No other significant correlations were encountered between the studied items.

Conclusions: NGAL values are increased in patients with high intraabdominal pressure which may suggest its utility as a cut off marker for patients with increased intraabdominal pressure. There is a significant decreased GFR in patient with elevated intraabdominal pressure, observation which can help in early detection of renal injury in patients due to high intraabdominal pressure. No correlation was found between creatinine clearance and increased intraabdominal pressure.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • 1. Bradley SE Bradley GP. The effect of increased intraabdominal pressure on renal function in man. J Clin Invest. 1947;26:1010-1022.

  • 2. Mohmand H Goldfarb S. Renal dysfunction associated with intraabdominal hypertension and the abdominal compartment syndrome. J Am Soc Nephrol. 2011;22:615-621.

  • 3. Malbrain ML Chiumello D Pelosi P. Prevalence of intraabdominal hypertension in critically ill patients: a multicentre epidemiological study. Intensive Care Med. 2004;30(5):822-9.

  • 4. Vidal MG Ruiz Weisser J Gonzalez F et al. Incidence and clinical effects of intraabdominal hypertension in critically ill patients. Crit Care Med. 2008;36(6):1823-31.

  • 5. Kirkpatrick AW Roberts DJ De Waele J et al. Intraabdominal hypertension and the abdominal compartment syndrome: updated consensus definitions and clinical practice guidelines from the World Society of the Abdominal Compartment Syndrome. Intensive Care Medicine. 2013;399(7):1190–1206.

  • 6. Puiac C Szederjesi J Lazar A Rad P Almasy E Pușcasiu L. Influence of Ventilation Parameters on Intraabdominal Pressure. The Journal of Critical Care Medicine 2016;2(2):80-84

  • 7. Sui F Zheng Y Li WX. Renal circulation and microcirculation during intraabdominal hypertension in a porcine model. Eur Rev Med Pharmacol Sci. 2016;20(3):452-61

  • 8. Balogh ZJ Lumsdaine W Moore EE. Postinjury abdominal compartment syndrome: from recognition to prevention. Lancet. 2014;384(9952):1466–1475

  • 9. Prasad D. Neutrophil gelatinase-associated lipocalin Neutrophil gelatinase-associated lipocalin (NGAL). A new marker of kidney disease. Scand J Clin Lab Invest Suppl. 2008;241:89–94

  • 10. Garabed E Lameire N. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney inter. Suppl. 2012;2:1–138

  • 11. Soni SS Bobek DC. NGAL: a biomarker of acute kidney injury and other systemic conditions. International Urology and Nephrology. 2010;42(1):141–150

  • 12. Laet IE Malbrain M. Current insights in intraabdominal hypertension and abdominal compartment syndrome. Med Intensiva. 2007;31(2):88-99

  • 13. Devarajan P. Neutrophil gelatinase-associated lipocalin (NGAL): a new marker of kidney disease. Scand J Clin Lab Invest Suppl. 2008;241():89-94

  • 14. Axelsson L Bergenfeldt M Ohlsson K. Studies of the release and turnover of a human neutrophil lipocalin. Scand J Clin Lab Invest. 1995; 55(7):577-88

  • 15. Cai L Rubin J Han W et al. The origin of multiple molecular forms in urine of HNL/NGAL. Clin J Am Soc Nephrol. 2010; 5(12):2229-35.

  • 16. Cai L Borowiec J Xu S Han W Venge P. Assays of urine levels of HNL/NGAL in patients undergoing cardiac surgery and the impact of antibody configuration on their clinical performances. Clin Chim Acta. 2009; 403:121.

  • 17. Glassford NJ Schneider AG Xu S et al. The nature and discriminatory value of urinary neutrophil gelatinase-associated lipocalin in critically ill patients at risk of acute kidney injury. Intensive Care Med. 2013;39:1714.

  • 18. Linko R Pettila V Kuitunen A et al. Plasma neutrophil gelatinase-associated lipocalin and adverse outcome in critically ill patients with ventilatory support. Acta Anaesthesiol Scand. 2013;57:855.

  • 19. L. Ke H.B. Ni Z.H. Tong et al. The importance of timing of decompression in severe acute pancreatitis combined with abdominal compartment syndrome. J Trauma Acute Care Surg. 2013;74:1060–1066

  • 20. Hjortrup PB Haase N Wetterslev M et al. Clinical review: Predictive value of neutrophil gelatinase-associated lipocalin for acute kidney injury in intensive care patients. Crit Care. 2013;17(2):211.013

  • 21. Patel ML Sachan R Verma A Kamal R Gupta KK. Neutrophil gelatinase-associated lipocalin as a biomarker of disease progression in patients with chronic kidney disease. Indian J Nephrol. 2016;26(2):125-30.

  • 22. Munna LP Rekha S Misra M Ritul K Radhey S Pushpalata S. Prognostic significance of urinary NGAL in chronic kidney disease. Int J NephrolRenovasc Dis. 2015;8:139–144.

Search
Journal information
Metrics
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 232 125 3
PDF Downloads 124 75 2